Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
Achieving optimal vaccination rates is vital for protecting the health and well-being of all individuals. This specific study focuses on the MMR and RSV vaccines in pregnancy and early childhood, which have been shown to reduce RSV and MMR-related illnesses, hospitalizations, and deaths. Efforts to improve vaccination
| Condition(s) | Vaccine Hesitancy, Vaccine Refusal |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Achieving optimal vaccination rates is vital for protecting the health and well-being of all individuals. This specific study focuses on the MMR and RSV vaccines in pregnancy and early childhood, which have been shown to reduce RSV and MMR-related illnesses, hospitalizations, and deaths. Efforts to improve vaccination rates have not been equally effective across the entire population; this has resulted in poorer outcomes from interventions for certain populations who are vaccine-hesitant. This study seeks to understand how to best increase vaccine confidence in marginalized populations. To do this, the investigators will interview parents of children who receive care at Boston Medical Center (BMC), Community Health Workers and other Clinical providers at BMC, leading experts in the fields |
| Who can participate | Inclusion Criteria: Parent and child- * The birthing parent of any age of a child (aged 12-24 months) who receives primary care at Boston Medical Center * A birthing parent who is registered as a patient at Boston Medical Center * The birthing parent must have been pregnant between the months of October and February (RSV season) * The birthing parent must be comfortable completing an interview in English, Spanish, or Haitian Creole. Clinician * Clinical provider (including Community Health Workers, Physicians, Physician Assistants and Nurse Practitioners) aged 18+ years at Boston Medical Center within Pediatrics, Family Medicine, or OB/GYN. These clinicians will have been involved in past or current successful vaccine-specific Evidence Based Interventions (EBI) beyond BMC and its affiliate |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Boston Medical Center |
| Locations | Boston, Massachusetts, United States |
| Start date | 2025-01-31 |
| NCT ID | NCT06639386 |
| Official listing | https://clinicaltrials.gov/study/NCT06639386 |